Lee CK - Search Results

1

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus.

Woo HY, Choi JY, Yoon SK, Suh DJ, Paik SW, Han KH, Um SH, Kim BI, Lee HJ, Cho M, Lee CK, Kim DJ, Hwang JS. Woo HY, et al. Among authors: lee ck, lee hj. Clin Mol Hepatol. 2014 Jun;20(2):168-76. doi: 10.3350/cmh.2014.20.2.168. Epub 2014 Jun 30. Clin Mol Hepatol. 2014. PMID: 25032183 Free PMC article.

2

[Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].

Lee CK, Suh JH, Cho YS, Han KH, Chung JB, Chon CY, Moon YM. Lee CK, et al. Taehan Kan Hakhoe Chi. 2002 Jun;8(2):139-48. Taehan Kan Hakhoe Chi. 2002. PMID: 12499799 Korean.

3

[Adequacy of immediate Lamivudine trial for chronic hepatitis B patients with acute exacerbation].

Lee CK, Suh JH, Cho YS, Won SY, Park IS. Lee CK, et al. Korean J Hepatol. 2004 Mar;10(1):22-30. Korean J Hepatol. 2004. PMID: 15096714 Clinical Trial. Korean.

4

[HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].

Lee CK, Han KH, Suh JH, Cho YS, Won SY, Chon CY, Moon YM, Park IS. Lee CK, et al. Korean J Hepatol. 2005 Mar;11(1):34-42. Korean J Hepatol. 2005. PMID: 15788883 Korean.

5

Efficacy of adefovir dipivoxil in the treatment of lamivudine-resistant hepatitis B virus genotype C infection.

Kim DY, Kim HJ, Lee CK, Suh JH, Kim DH, Cho YS, Won SY, Park BK, Park IS. Kim DY, et al. Among authors: lee ck. Liver Int. 2007 Feb;27(1):47-53. doi: 10.1111/j.1478-3231.2006.01407.x. Liver Int. 2007. PMID: 17241380 Clinical Trial.

6

Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.

Kim JS, Hahn JS, Park SY, Kim Y, Park IH, Lee CK, Cheong JW, Lee ST, Min YH. Kim JS, et al. Among authors: lee ck, lee st. Yonsei Med J. 2007 Feb 28;48(1):78-89. doi: 10.3349/ymj.2007.48.1.78. Yonsei Med J. 2007. PMID: 17326249 Free PMC article.

7

Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.

Lee JM, Kim HJ, Park JY, Lee CK, Kim DY, Kim JK, Lee HW, Paik YH, Lee KS, Han KH, Chon CY, Hong SP, Nguyen T, Ahn SH. Lee JM, et al. Among authors: lee ck, lee ks, lee hw. Antivir Ther. 2009;14(5):705-12. Antivir Ther. 2009. PMID: 19704174 Clinical Trial.

8

Association between polymorphism of tumor necrosis factor-alpha promoter and response to lamivudine treatment in patients with chronic hepatitis B.

Park YK, Lee JM, Kim DY, Chang HY, Kim JK, Lee CK, Park JY, Ahn SH, Lee KS, Han KH. Park YK, et al. Among authors: lee ck, lee ks, lee jm. Dig Dis Sci. 2010 Jul;55(7):2043-8. doi: 10.1007/s10620-009-0983-1. Epub 2009 Oct 15. Dig Dis Sci. 2010. PMID: 19830555

9

Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis.

Kim SU, Kim DY, Lee CK, Park JY, Kim SH, Kim HM, Choi EH, Kim S, Han KH, Chon CY, Ahn SH. Kim SU, et al. Among authors: lee ck. J Gastroenterol Hepatol. 2010 Jan;25(1):122-8. doi: 10.1111/j.1440-1746.2009.05970.x. Epub 2009 Oct 19. J Gastroenterol Hepatol. 2010. PMID: 19845823

10

Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B.

Lee HW, Lee HJ, Hwang JS, Sohn JH, Jang JY, Han KJ, Park JY, Kim DY, Ahn SH, Paik YH, Lee CK, Lee KS, Chon CY, Han KH. Lee HW, et al. Among authors: lee ck, lee ks, lee hj. Hepatology. 2010 Feb;51(2):415-21. doi: 10.1002/hep.23323. Hepatology. 2010. PMID: 19902424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,286 results

Search Page

Filters